Investors should have a “keep calm and carry on” approach to financial markets, maintaining a long position in emerging ...

With the pull-forward effect ahead of tariff implementation over, the US vehicle market is expected to slow further in H2.

GlobalData, using its Ai Palette platform, presents the ingredients it believes offer opportunities for confectioners to win over snack lovers.

Organon is terminating development of its endometriosis drug after the Phase II trial failed to show any benefit. The ELENA ...

Mexico could gain strategic benefits in the current trade environment, as companies look to relocate production within North ...

The endometriosis market is expected to grow from $938.0m in 2024 to $2.5 billion in 2034, at a compound annual growth rate ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis portfolio.

India's mobile services revenue is set to rise at a CAGR of 5.4% to reach $39.3 billion by 2029, driven by enhanced mobile ...

War risk cover, once a niche product, is re-emerging as a critical discussion point,' says data and analytics firm ...

Nike is forecasting it will have to pay $1 billion in additional costs because of President Donald Trump’s tariffs, the ...

The combined group could potentially 'almost double the joint second-largest players' market share', says analyst ...

As North American sales decline and excess inventory looms, Nike aims for a cleaner inventory by fiscal 2026 while pivoting ...